...with AF Portola Pharmaceuticals Inc. (NASDAQ:PTLA) Betrixaban (small molecule) Phase III VTE Phase II Stroke TeaRx LLC...

...with Roche (see BioCentury, May 30, 2011). Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) markets Lovenox enoxaparin. TeaRx LLC...

...Roche granted newco TeaRx exclusive rights to develop and commercialize preclinical oral Factor Xa inhibitors in...
...develop and commercialize preclinical oral Factor Xa inhibitors in Russia and 11 other undisclosed countries. TeaRx...
...for the trials and is eligible for milestones and royalties. Financial terms were not disclosed. TeaRx...